Investigative Site

Dupnitsa 2600

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed